Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 Jan;37(1):21-30.
doi: 10.1007/s10545-013-9624-0. Epub 2013 Jun 19.

Cross-sectional Observational Study of 208 Patients With Non-Classical Urea Cycle Disorders

Affiliations
Free PMC article
Observational Study

Cross-sectional Observational Study of 208 Patients With Non-Classical Urea Cycle Disorders

Corinne M Rüegger et al. J Inherit Metab Dis. .
Free PMC article

Abstract

Urea cycle disorders (UCDs) are inherited disorders of ammonia detoxification often regarded as mainly of relevance to pediatricians. Based on an increasing number of case studies it has become obvious that a significant number of UCD patients are affected by their disease in a non-classical way: presenting outside the newborn period, following a mild course, presenting with unusual clinical features, or asymptomatic patients with only biochemical signs of a UCD. These patients are surviving into adolescence and adulthood, rendering this group of diseases clinically relevant to adult physicians as well as pediatricians. In preparation for an international workshop we collected data on all patients with non-classical UCDs treated by the participants in 20 European metabolic centres. Information was collected on a cohort of 208 patients 50% of which were ≥ 16 years old. The largest subgroup (121 patients) had X-linked ornithine transcarbamylase deficiency (OTCD) of whom 83 were female and 29% of these were asymptomatic. In index patients, there was a mean delay from first symptoms to diagnosis of 1.6 years. Cognitive impairment was present in 36% of all patients including female OTCD patients (in 31%) and those 41 patients identified presymptomatically following positive newborn screening (in 12%). In conclusion, UCD patients with non-classical clinical presentations require the interest and care of adult physicians and have a high risk of neurological complications. To improve the outcome of UCDs, a greater awareness by health professionals of the importance of hyperammonemia and UCDs, and ultimately avoidance of the still long delay to correctly diagnose the patients, is crucial.

Figures

Fig. 1
Fig. 1
Age distribution of all patients (n = 208). Each column in this graph represents one patient. The line at age 16 is separating pediatric from adult patients (patient 104 being the first adult)
Fig. 2
Fig. 2
Diagnostic delay between onset of first symptoms and diagnosis of a UCD in years for the 91 patients diagnosed because of symptoms. Each dot represents one patient
Fig. 3
Fig. 3
Frequency of acute crisis in each disease (OTCD, ASSD, ASLD and ARG1D, as well as total including HHH syndrome, NAGSD, CPS1D) (data from 204 patients) and the proportions of MR/DD (data from 208 patients)
Fig. 4
Fig. 4
Pharmacological treatment with Na-Benzoate and Na-Phenylbutyrate (4a) (data from 196 patients) as well as supplements of L-arginine and L-citrulline (4b) (data from 199 patients)

Similar articles

  • Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C, Das A, Valayannopoulos V, Thimm E, Beblo S, Burlina A, Konstantopoulou V, Mayorandan S, de Lonlay P, Rennecke J, Derbinski J, Hoffmann GF, Häberle J. Unsinn C, et al. Orphanet J Rare Dis. 2016 Aug 19;11(1):116. doi: 10.1186/s13023-016-0493-0. Orphanet J Rare Dis. 2016. PMID: 27538463 Free PMC article. Clinical Trial.
  • Long-term outcome and intervention of urea cycle disorders in Japan.
    Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, Yoshino M, Shigematsu Y, Yorifuji T, Kasahara M, Horikawa R, Endo F. Kido J, et al. J Inherit Metab Dis. 2012 Sep;35(5):777-85. doi: 10.1007/s10545-011-9427-0. Epub 2011 Dec 14. J Inherit Metab Dis. 2012. PMID: 22167275
  • Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.
    Posset R, Gropman AL, Nagamani SCS, Burrage LC, Bedoyan JK, Wong D, Berry GT, Baumgartner MR, Yudkoff M, Zielonka M, Hoffmann GF, Burgard P, Schulze A, McCandless SE, Garcia-Cazorla A, Seminara J, Garbade SF, Kölker S; Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases Consortia Study Group. Posset R, et al. Ann Neurol. 2019 Jul;86(1):116-128. doi: 10.1002/ana.25492. Epub 2019 May 13. Ann Neurol. 2019. PMID: 31018246 Clinical Trial.
  • Suggested guidelines for the diagnosis and management of urea cycle disorders.
    Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici C. Häberle J, et al. Orphanet J Rare Dis. 2012 May 29;7:32. doi: 10.1186/1750-1172-7-32. Orphanet J Rare Dis. 2012. PMID: 22642880 Free PMC article. Review.
  • Urea cycle disorders: clinical presentation outside the newborn period.
    Smith W, Kishnani PS, Lee B, Singh RH, Rhead WJ, Sniderman King L, Smith M, Summar M. Smith W, et al. Crit Care Clin. 2005 Oct;21(4 Suppl):S9-17. doi: 10.1016/j.ccc.2005.05.007. Crit Care Clin. 2005. PMID: 16227115 Review.
See all similar articles

Cited by 17 articles

See all "Cited by" articles

References

    1. Bachmann C. Mechanisms of hyperammonemia. Clin Chem Lab Med. 2002;40:653–662. doi: 10.1515/CCLM.2002.112. - DOI - PubMed
    1. Berning C, Bieger I, Pauli S, et al. Investigation of citrullinemia type I variants by in vitro expression studies. Hum Mutat. 2008;29:1222–1227. doi: 10.1002/humu.20784. - DOI - PubMed
    1. Bogdanovic MD, Kidd D, Briddon A, Duncan JS, Land JM. Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry. 2000;69:813–815. doi: 10.1136/jnnp.69.6.813. - DOI - PMC - PubMed
    1. Brusilow SW. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis. J Clin Invest. 1984;74:2144–2148. doi: 10.1172/JCI111640. - DOI - PMC - PubMed
    1. Brusilow S, Horwich A. Urea cycle enzymes. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic & molecular bases of inherited disease. 8. New York: McGraw-Hill; 2001. pp. 1909–1963.

Publication types

MeSH terms

Feedback